Closing the Gaps in NSCLC

Closing the Gaps in NSCLC

By ReachMDMedicine
Download on the App Store

Closing the Gaps in NSCLC episodes

  • The Value of Multidisciplinary Teams in NSCLC Care Plans
    Guest: Edward S. Kim, MD

    At the very least, any successful non-small cell lung cancer (NSCLC) care team needs to include a medical oncologist, pulmonologist, pathologist, radiologist, and even a molecular pathologist. Reviewing the value of each of these roles in tackling NSCLC is Dr. Edward Kim, Chair of Solid Tumor Oncology and Investigational Therapeutics at Levine Cancer Institute.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Dissecting Determinants of Disease Progression in NSCLC
    Guest: Howard (Jack) West, MD

    With many factors yet to be discovered, Dr. Howard Jack West targets the clinical characteristics and molecular markers associated with disease progression in non-small cell lung cancer (NSCLC) patients. As he presents patterns observed for decades, Dr. West reveals other often underrecognized clues that drive disease progression.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Breakthrough Breakdown: Impacts of Keynote-189
    Host: Shira Johnson, MD
    Guest: Howard (Jack) West, MD

    With profound results, Keynote-189 has led to change in the vast majority of U.S.-based oncologists, so now it's time to take a closer look.

    Dr. Shira Johnson welcomes Dr. Howard Jack West, who leads us on a deep dive into the clinical trial. From the study design to clinical implications, Dr. West highlights key findings, which may just unlock a new standard of care and better patient outcomes.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • How KEYNOTE-189 Transformed Clinical Practice Overnight
    Guest: Howard (Jack) West, MD

    Proven to be both statistically and clinically significant, KEYNOTE-189 has offered pivotal outcomes for patients with non-small cell lung cancer (NSCLC). Join Dr. Howard Jack West as he analyzes the substantial influence of this clinical trial.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min
  • Combination to Combat: Second Line Therapy Options for NSCLC
    Guest: Howard (Jack) West, MD

    Chemoimmunotherapy has become more prevalent as a first-line treatment option for patients with non-small cell lung cancer (NSCLC). However, by compressing two therapies into one, we could be left with fewer alternatives if patients progress. Dr. Howard Jack West exposes these potential challenges and offers his perspective on second-line approaches in NSCLC care.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    0 min

About Closing the Gaps in NSCLC

From the publisher's feed

Not only is lung cancer the leading cause of cancer deaths among females and males, but it’s also the most common type of cancer. Despite its high prevalence and mortality rates, communicative care between non-small cell lung cancer (NSCLC) patients and their providers is still unfortunately lacking.